|4Mar 8, 9:07 AM ET

AGARWAL SUNIL 4

4 · Sana Biotechnology, Inc. · Filed Mar 8, 2022

Insider Transaction Report

Form 4
Period: 2022-03-03
AGARWAL SUNIL
See Remarks
Transactions
  • Award

    Stock Options (Right to Buy)

    2022-03-03+250,000250,000 total
    Exercise: $5.70Exp: 2032-03-02Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on March 3, 2023 and in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT